Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL)
Crossref DOI link: https://doi.org/10.1007/s11060-016-2293-8
Published Online: 2016-10-17
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kuitunen, Hanne http://orcid.org/0000-0001-7328-2043
Tokola, Susanna
Siniluoto, Topi
Isokangas, Matti
Sonkajärvi, Eila
Alahuhta, Seppo
Turpeenniemi-Hujanen, Taina
Jantunen, Esa
Nousiainen, Tapio
Vasala, Kaija
Kuittinen, Outi
License valid from 2016-10-17